相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature
Feby Savira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
T Cells Play a Causal Role in Diastolic Dysfunction during Uremic Cardiomyopathy
Pamela D. Winterberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
The role of disordered angiogenesis tissue markers (sFlt-1, PIGF) in present day diagnosis of preeclampsia
Sebastian Kwiatkowski et al.
GINEKOLOGIA POLSKA (2019)
Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review
Nicole Draker et al.
BIOMARKERS IN MEDICINE (2019)
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Andrew A. House et al.
KIDNEY INTERNATIONAL (2019)
Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome
Anna Clementi et al.
CARDIORENAL MEDICINE (2019)
Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity
Seung-Ah Yoo et al.
NATURE IMMUNOLOGY (2019)
AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels
Yasuki Nakada et al.
SCIENTIFIC REPORTS (2019)
Value of Placental Growth Factor as a Predictor of Adverse Events During the Acute Phase of Acute Decompensated Heart Failure
Yasuki Nakada et al.
CIRCULATION JOURNAL (2019)
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry
Jasper Tromp et al.
PLOS MEDICINE (2018)
Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
Suree Lekawanvijit
TOXINS (2018)
Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure
Muhammad Hammadah et al.
CIRCULATION-HEART FAILURE (2016)
Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure
Ayako Seno et al.
HYPERTENSION (2016)
Soluble Flt-1 links microvascular disease with heart failure in CKD
Giovana S. Di Marco et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?
Asif Ahmed et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study
Masaru Matsui et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease
Masaru Matsui et al.
KIDNEY INTERNATIONAL (2014)
Worsening of Renal Function During 1 Year After Hospital Discharge Is a Strong and Independent Predictor of All-Cause Mortality in Acute Decompensated Heart Failure
Tomoya Ueda et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
Masabumi Shibuya
JOURNAL OF BIOCHEMISTRY (2013)
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease - a prospective observational study
Martina Peiskerova et al.
BMC NEPHROLOGY (2013)
Aldosterone Increases Early Atherosclerosis and Promotes Plaque Inflammation Through a Placental Growth Factor-Dependent Mechanism
Adam P. McGraw et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
PlGF: A Multitasking Cytokine with Disease-Restricted Activity
Mieke Dewerchin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Heparin Elevates Circulating Soluble fms-Like Tyrosine Kinase-1 Immunoreactivity in Pregnant Women Receiving Anticoagulation Therapy
Victor A. Rosenberg et al.
CIRCULATION (2011)
Local Retention Versus Systemic Release of Soluble VEGF Receptor-1 Are Mediated by Heparin-Binding and Regulated by Heparanase
Shay Sela et al.
CIRCULATION RESEARCH (2011)
The Vascular Marker Soluble Fms-Like Tyrosine Kinase 1 Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors
Hiroto Iwasaki et al.
PLOS ONE (2011)
Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions
Carmen Roncal et al.
CARDIOVASCULAR RESEARCH (2010)
Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice
Tomoki Kosugi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Usefulness of Soluble Fms-like Tyrosine Kinase-1 as a Biomarker of Acute Severe Heart Failure in Patients With Acute Myocardial Infarction
Kenji Onoue et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Reduction of Circulating Soluble Fms-Like Tyrosine Kinase-1 Plays a Significant Role in Renal Dysfunction-Associated Aggravation of Atherosclerosis
Kenji Onoue et al.
CIRCULATION (2009)
Treatment With Recombinant Placental Growth Factor (PIGF) Enhances Both Angiogenesis and Arteriogenesis and Improves Survival After Myocardial Infarction
Yukiji Takeda et al.
CIRCULATION JOURNAL (2009)
Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
Michel Komajda et al.
EUROPEAN HEART JOURNAL (2009)
The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD
Giovana S. Di Marco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
A novel human-specific soluble vascular endothelial growth factor receptor 1 - Cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia
Shay Sela et al.
CIRCULATION RESEARCH (2008)
Cardiorenal Syndrome
Claudio Ronco et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome
A. Palazzuoli et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction
H Iwama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes
T Lenderink et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation
R Khurana et al.
CIRCULATION (2005)
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
H Takahashi et al.
CLINICAL SCIENCE (2005)
Prognostic value of placental growth factor in patients with acute chest pain
C Heeschen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet et al.
NATURE MEDICINE (2001)
分享论文
